Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Transarterial Chemoembolization (TACE)

Clinical Trials

    • Cancer(4)
  • Phase 1 Cancers

    A Randomized Controlled Study of the Efficacy of Hepatic Arterial Perfusion Chemotherapy Concurrently Compared to Sequentially Combined With Targeted and Immunotherapy in Potentially Resectable Intermediate and Advanced HCC

    • Kidney Cancer, Head and Neck Cancers, Lung Cancer, Melanoma

      XTX301 in Patients With Advanced Solid Tumors

      • Phase 1 Cancers

        A Phase 1, Open Label, Multiple Dose, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of the PTK7-Targeted Antibody-drug Conjugate DAY301 in Patients With Locally Advanced or Metastatic Solid Tumors

        • Phase 1 Cancers

          A Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of a Folate Receptor Alpha Antibody Drug Conjugate, ZW191, in Participants With Advanced Solid Tumors

          • About Us
          • Contact Us
          • Donate
          • Referring Doctors
          • Clinical Keywords

          333 Cedar St.

          New Haven, CT 06510

          • Yale School of Medicine
          • Yale University
          • Terms & Privacy Policies
          • Accessibility at YSM
          • Patient Rights
          • HIPAA at Yale
          • Non-discrimination Statement
          Copyright 2026 Yale Medicine